Journal article

SOX9 regulates ERBB signalling in pancreatic cancer development

Adrien Grimont, Andreia V Pinho, Mark J Cowley, Cecile Augereau, Amanda Mawson, Marc Giry-Laterriere, Geraldine Van den Steen, Nicola Waddell, Marina Pajic, Christine Sempoux, Jianmin Wu, Sean M Grimmond, Andrew V Biankin, Frederic P Lemaigre, Ilse Rooman, Patrick Jacquemin

Gut | BMJ PUBLISHING GROUP | Published : 2015

University of Melbourne Researchers


Awarded by HGSC-BCM: NHGRI

Awarded by CPRIT grant

Awarded by Cancer Institute NSW

Awarded by Cancer Research UK


Funding Acknowledgements

This work was supported by grants from the Cancer Institute NSW; National Health and Medical Research Council of Australia; Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education; Australian Cancer Research Foundation; Queensland Government; University of Queensland; Cancer Council NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians; Royal College of Pathologists of Australasia; HGSC-BCM: NHGRI U54 HG003273; CPRIT grant RP101353-P7 (Tumour Banking for Genomic Research and Clinical Translation Site 1); Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique-FNRS (Belgium); Universite catholique de Louvain. AG was supported by a grant from EU FP7 (Marie Curie Initial Training Network BOLD) and a Televie fellowship. AVP and MJC are supported by early career fellowships from Cancer Institute NSW. CA holds a Televie fellowship, IR is a Future Research Fellow of the Cancer Institute NSW (10/FRL2-03) and PJ is a Research Associate of the Fonds de la Recherche Scientifique-FNRS.